PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GILD vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GILD and JNJ is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

GILD vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

0.00%5,000.00%10,000.00%15,000.00%20,000.00%AugustSeptemberOctoberNovemberDecember2025
20,223.08%
1,947.71%
GILD
JNJ

Key characteristics

Sharpe Ratio

GILD:

0.43

JNJ:

-0.35

Sortino Ratio

GILD:

0.76

JNJ:

-0.41

Omega Ratio

GILD:

1.11

JNJ:

0.95

Calmar Ratio

GILD:

0.35

JNJ:

-0.31

Martin Ratio

GILD:

0.72

JNJ:

-0.79

Ulcer Index

GILD:

14.63%

JNJ:

6.88%

Daily Std Dev

GILD:

24.51%

JNJ:

15.48%

Max Drawdown

GILD:

-70.82%

JNJ:

-52.60%

Current Drawdown

GILD:

-5.40%

JNJ:

-14.32%

Fundamentals

Market Cap

GILD:

$114.46B

JNJ:

$353.99B

EPS

GILD:

$0.09

JNJ:

$6.04

PE Ratio

GILD:

1.02K

JNJ:

24.34

PEG Ratio

GILD:

0.53

JNJ:

0.86

Total Revenue (TTM)

GILD:

$21.18B

JNJ:

$66.30B

Gross Profit (TTM)

GILD:

$16.51B

JNJ:

$45.96B

EBITDA (TTM)

GILD:

$1.33B

JNJ:

$22.61B

Returns By Period

In the year-to-date period, GILD achieves a -0.57% return, which is significantly lower than JNJ's 1.67% return. Over the past 10 years, GILD has underperformed JNJ with an annualized return of 2.19%, while JNJ has yielded a comparatively higher 6.72% annualized return.


GILD

YTD

-0.57%

1M

0.82%

6M

28.83%

1Y

9.51%

5Y*

12.36%

10Y*

2.19%

JNJ

YTD

1.67%

1M

1.58%

6M

-3.46%

1Y

-5.91%

5Y*

2.52%

10Y*

6.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GILD vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GILD
The Risk-Adjusted Performance Rank of GILD is 5757
Overall Rank
The Sharpe Ratio Rank of GILD is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of GILD is 5353
Sortino Ratio Rank
The Omega Ratio Rank of GILD is 5454
Omega Ratio Rank
The Calmar Ratio Rank of GILD is 6262
Calmar Ratio Rank
The Martin Ratio Rank of GILD is 5555
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2626
Overall Rank
The Sharpe Ratio Rank of JNJ is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2323
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2828
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GILD vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GILD, currently valued at 0.43, compared to the broader market-2.000.002.004.000.43-0.35
The chart of Sortino ratio for GILD, currently valued at 0.76, compared to the broader market-4.00-2.000.002.004.000.76-0.41
The chart of Omega ratio for GILD, currently valued at 1.11, compared to the broader market0.501.001.502.001.110.95
The chart of Calmar ratio for GILD, currently valued at 0.35, compared to the broader market0.002.004.006.000.35-0.31
The chart of Martin ratio for GILD, currently valued at 0.72, compared to the broader market-10.000.0010.0020.000.72-0.79
GILD
JNJ

The current GILD Sharpe Ratio is 0.43, which is higher than the JNJ Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of GILD and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.43
-0.35
GILD
JNJ

Dividends

GILD vs. JNJ - Dividend Comparison

GILD's dividend yield for the trailing twelve months is around 3.35%, which matches JNJ's 3.34% yield.


TTM20242023202220212020201920182017201620152014
GILD
Gilead Sciences, Inc.
3.35%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%0.00%
JNJ
Johnson & Johnson
3.34%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

GILD vs. JNJ - Drawdown Comparison

The maximum GILD drawdown since its inception was -70.82%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for GILD and JNJ. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-5.40%
-14.32%
GILD
JNJ

Volatility

GILD vs. JNJ - Volatility Comparison

Gilead Sciences, Inc. (GILD) and Johnson & Johnson (JNJ) have volatilities of 5.04% and 5.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
5.04%
5.21%
GILD
JNJ

Financials

GILD vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab